STAT5B and cancer: Owing to their ability to regulate the expression of genes involved in cell-cycle regulation (cyclin D1, c-myc, and p21) and cellular survival (Bcl-XL), STAT5a and STAT5b have emerged as possible targets for cancer therapeutics [10].